Berg SL - Search Results

1

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shaughnessy J, et al. Wilson WH, et al. Among authors: berg sl. J Clin Oncol. 1994 Aug;12(8):1621-9. doi: 10.1200/JCO.1994.12.8.1621. J Clin Oncol. 1994. PMID: 7913721 Clinical Trial.

2

Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.

Berg SL, Balis FM, Zimm S, Murphy RF, Holcenberg J, Sato J, Reaman G, Steinherz P, Gillespie A, Doherty K, et al. Berg SL, et al. J Clin Oncol. 1992 Jan;10(1):143-8. doi: 10.1200/JCO.1992.10.1.143. J Clin Oncol. 1992. PMID: 1727916 Clinical Trial.

3

Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.

Berg SL, Tolcher A, O'Shaughnessy JA, Denicoff AM, Noone M, Ognibene FP, Cowan KH, Balis FM. Berg SL, et al. J Clin Oncol. 1995 Aug;13(8):2039-42. doi: 10.1200/JCO.1995.13.8.2039. J Clin Oncol. 1995. PMID: 7636546 Clinical Trial.

4

A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.

Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG. Adamson PC, et al. Among authors: berg sl. Cancer Res. 1995 Sep 15;55(18):4069-72. Cancer Res. 1995. PMID: 7664282 Clinical Trial.

5

Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.

Berg SL, Savarese DM, Balis FM, Denicoff AM, Hillig M, O'Shaughnessy JA, Poplack DG, Cowan KH. Berg SL, et al. Cancer Res. 1993 Jun 1;53(11):2587-90. Cancer Res. 1993. PMID: 7684320 Clinical Trial.

6

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.

Savarese DM, Denicoff AM, Berg SL, Hillig M, Baker SP, O'Shaughnessy JA, Chow C, Otterson GA, Balis FM, Poplack DG, et al. Savarese DM, et al. Among authors: berg sl. J Clin Oncol. 1993 Sep;11(9):1795-803. doi: 10.1200/JCO.1993.11.9.1795. J Clin Oncol. 1993. PMID: 7689093 Clinical Trial.

7

Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.

Berg SL, Cowan KH, Balis FM, Fisherman JS, Denicoff AM, Hillig M, Poplack DG, O'Shaughnessy JA. Berg SL, et al. J Natl Cancer Inst. 1994 Jan 19;86(2):143-5. doi: 10.1093/jnci/86.2.143. J Natl Cancer Inst. 1994. PMID: 7903702 No abstract available.

8

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.

Wexler LH, Andrich MP, Venzon D, Berg SL, Weaver-McClure L, Chen CC, Dilsizian V, Avila N, Jarosinski P, Balis FM, Poplack DG, Horowitz ME. Wexler LH, et al. Among authors: berg sl. J Clin Oncol. 1996 Feb;14(2):362-72. doi: 10.1200/JCO.1996.14.2.362. J Clin Oncol. 1996. PMID: 8636745 Clinical Trial.

9

Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.

Tolcher AW, Cowan KH, Solomon D, Ognibene F, Goldspiel B, Chang R, Noone MH, Denicoff AM, Barnes CS, Gossard MR, Fetsch PA, Berg SL, Balis FM, Venzon DJ, O'Shaughnessy JA. Tolcher AW, et al. Among authors: berg sl. J Clin Oncol. 1996 Apr;14(4):1173-84. doi: 10.1200/JCO.1996.14.4.1173. J Clin Oncol. 1996. PMID: 8648372 Clinical Trial.

10

Phase II evaluation of topotecan for pediatric central nervous system tumors.

Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM. Blaney SM, et al. Among authors: berg sl. Cancer. 1996 Aug 1;78(3):527-31. doi: 10.1002/(SICI)1097-0142(19960801)78:3<527::AID-CNCR21>3.0.CO;2-#. Cancer. 1996. PMID: 8697400 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page